Free Trial
→ Crypto’s crashing…but we’re still profiting (From Crypto Swap Profits) (Ad) Buy RARE Stock  Free RARE Stock Alerts

Ultragenyx Pharmaceutical (RARE) SEC Filings & 10K Form

Ultragenyx Pharmaceutical logo
$35.34 +0.42 (+1.20%)
Closing price 04:00 PM Eastern
Extended Trading
$35.34 0.00 (0.00%)
As of 05:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Ultragenyx Pharmaceutical SEC Filings

Export to Excel
DateFilerForm TypeView
03/28/2025
4:00 PM		Ultragenyx Pharmaceutical (Filer)
Form DEF 14A
03/28/2025
4:01 PM		Ultragenyx Pharmaceutical (Filer)
Form DEFA14A
03/28/2025
4:02 PM		Ultragenyx Pharmaceutical (Filer)
Form ARS
03/10/2025
11:53 AM		Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:16 PM		Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:18 PM		Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:19 PM		Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:56 PM		Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM		Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:02 PM		Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:06 PM		Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:10 PM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:12 PM		Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
12:58 PM		Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:58 PM		Ultragenyx Pharmaceutical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
10:42 AM		SANDS CAPITAL MANAGEMENT, LLC (Filed by)
Ultragenyx Pharmaceutical (Subject)
Form SCHEDULE 13G/A
02/10/2025
9:25 AM		Ultragenyx Pharmaceutical (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
01/13/2025
7:30 AM		Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2024
1:05 PM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:32 PM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2024
3:17 PM		Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
7:30 AM		Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
5:44 PM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
5:47 PM		Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:12 PM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
5:42 AM		RTW INVESTMENTS, LP (Filed by)
Ultragenyx Pharmaceutical (Subject)
Form SC 13G/A
11/05/2024
3:06 PM		Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
3:48 PM		Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
7:15 AM		Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:34 PM		Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
12:03 PM		Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
10:50 AM		Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
10:53 AM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:40 PM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
1:48 PM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:28 PM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
1:07 PM		Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:22 PM		Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:23 PM		Ray Amrit (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:24 PM		NARACHI MICHAEL (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:25 PM		Ultragenyx Pharmaceutical (Issuer)
WELCH DANIEL G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Altucher: Turn $900 into $108,000 in just 12 months? (Ad)

We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.

If I’m right about this (like I was before) a modest $900 investment…
06/20/2024
1:26 PM		Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:29 PM		Dunsire Deborah (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:22 PM		SULIMAN SHEHNAAZ (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
5:31 AM		Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
4:11 PM		Ultragenyx Pharmaceutical (Filer)
Form 424B5
06/12/2024
6:47 PM		Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
4:10 PM		Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2024
4:20 PM		Ultragenyx Pharmaceutical (Filer)
Form 424B5
06/10/2024
6:58 PM		Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
4:20 PM		Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2024
2:23 PM		Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
3:35 PM		Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
5:06 PM		Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
7:07 AM		Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:RARE) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Elon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...
InvestorPlace | Sponsored
America’s Retirement Accounts Are at Risk—Here’s Why
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored